Bionorica   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Neumarkt Germany (1933)
Status: No NME R&D (1933)

Organization Overview

First Clinical Trial
2007
NCT00959218
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bionorica Research GmbH | Bionorica SE